Donegal Group Inc. Announces Release Date for Fourth Quarter and Full-Year 2024 Results
Earnings Release Announcement: Donegal Group Inc. will release its fourth quarter and full-year results for 2024 on February 20, 2025, before NASDAQ trading begins, along with a supplemental investor presentation available on their website.
Management Commentary Webcast: A pre-recorded audio webcast featuring management commentary and a Q&A session will be available at 8:30 am ET on the same day, with questions to be submitted via email by February 13, 2025.
Trade with 70% Backtested Accuracy
Analyst Views on DGICB

No data
About DGICB
About the author

- Revenue Beat: Strategy reported fourth-quarter revenue of $122.99 million after Thursday's close, surpassing analyst expectations of $118.48 million, indicating strong market performance that may attract more investor interest.
- Earnings Growth: The company posted adjusted earnings of $16.37 per share, exceeding analyst estimates of $10.96 per share, demonstrating significant improvement in profitability that could lay the groundwork for future growth.
- Stock Price Decline: Despite the revenue and earnings beats, Strategy's stock dipped 4.8% to $128.36 in pre-market trading, reflecting market concerns about the overall economic environment, which may impact investor confidence.
- Market Trends: U.S. stock futures were lower, with Nasdaq 100 futures falling around 100 points, indicating cautious market sentiment that could pressure tech stocks and influence overall investment strategies.
- Dividend Announcement: Donegal Group's board declared a quarterly cash dividend of $0.1825 per share for Class A common stock and $0.165 for Class B, payable on February 17, 2026, reflecting the company's ongoing financial stability and commitment to shareholder returns.
- Shareholder Record: The dividend payment is based on the shareholder record as of the close of business on February 3, 2026, ensuring timely returns to investors and further enhancing investor confidence.
- Company Background: Donegal Group is an insurance holding company offering property and casualty insurance across 21 states, with an A.M. Best rating of A (Excellent), indicating its robust position in the insurance industry.
- Strategic Goals: The company focuses on achieving sustained excellent financial performance and modernizing operations, aiming to enhance market competitiveness through profitable growth opportunities and superior customer experiences.
- Dividend Declaration: Donegal Group's board has declared a quarterly cash dividend of $0.1825 per share for Class A common stock and $0.165 for Class B, payable on February 17, 2026, reflecting the company's ongoing financial stability.
- Shareholder Returns: This dividend payment will benefit shareholders of record as of February 3, 2026, indicating the company's commitment to enhancing shareholder value while showcasing its robust profitability.
- Market Positioning: Operating in 21 states, Donegal Group offers property and casualty insurance and holds an A.M. Best rating of A (Excellent), underscoring its strong competitive position and credibility in the insurance market.
- Strategic Objectives: The company focuses on modernizing operations and profitable growth, aiming to enhance market share by providing superior customer experiences and agent services, thereby solidifying its position in the insurance industry.
Dividend Declaration: Donegal Group Inc. announced a quarterly cash dividend of $0.1825 per share for Class A common stock and $0.165 per share for Class B common stock, payable on November 17, 2025, to stockholders of record by November 3, 2025.
Company Overview: Donegal Group Inc. is an insurance holding company operating in 21 states, offering property and casualty insurance, and is rated A (Excellent) by A.M. Best. The company focuses on financial performance, operational modernization, profitable growth, and enhancing experiences for agents, customers, and employees.

Earnings Release Announcement: Donegal Group Inc. will release its third-quarter results for the period ending September 30, 2025, on October 30, 2025, before NASDAQ trading begins, along with a supplemental investor presentation on its website.
Management Commentary and Q&A Session: A pre-recorded audio webcast featuring management commentary will be available at 8:30 am ET on the same day, followed by a Q&A session where questions can be submitted via email until October 23, 2025.

Celestica's Financial Performance: Celestica Inc. shares surged 12.1% in pre-market trading after reporting second-quarter earnings of $1.39 per share, exceeding analyst expectations, and raising its FY25 guidance along with third-quarter estimates.
Market Movements: Several stocks experienced significant pre-market trading movements, with Salarius Pharmaceuticals gaining 279.1%, while AIM ImmunoTech saw a decline of 40.9% following disappointing trial data.






